Description: This discussion from the 1983 SOA Hollywood, Florida Meeting presents an update for actuaries on U.S. Federal Statistics including GNP, economic accounts, measures of price change, the Federal Reserve, and the money supply. From Record of Society of Actuaries, Vol. 9, No. 4.

Description: This session meets the needs of life insurance actuaries who are focused on experience studies, assumption setting, and/or product development. The presenters will use industry data to illustrate how policyholders react to product design, such as premium jumps in the PLT period and UL with high interest rate illustration, and trends in the life insurance market, including the introduction of smoking distinguished rates and the shift towards an increasing number of preferred underwriting classes.

Description: Papers: Multi-Population Longevity Models: A Spatial Random Field Approach– Nhan Huynh, Mike Ludkovski, Ph.D. - University of California at Santa Barbara, Howard Zail - Elucider, LLC. The Application of Affine Processes in Cohort Mortality Risk Models – Zhiping Huang, Michael Sherris, FSA, FIAA, FIA, Andres M. Villegas Ramirez, Ph.D., Jonathan Ziveyi, Ph.D. - UNSW Australia

Description: In session 142OF of the Washington Annual Meeting panelists discuss key existing research projects as well as suggestions for new projects. From the Record of the Society of Actuaries, Vol. 23, No. 3.

Description: In September 2017, the China Insurance Regulatory Commission (CIRC) issued the “C-ROSS Phase II project construction plan”, planned to be used across three years’ time, by perfecting the regulations, improving the operational mechanism and strengthening the regulatory cooperation.

Description: This discussion examines the following of the subject of Morbidity statistics: What solutions are being found for development of morbidity statistics to meet the needs of individual companies? What changes, if any, in the Society's role as a collection agency for morbidity experience can be made to expedite such development? What uses of Health Statistics developed from the 1957-58 US National Health Survey have been made? From Transactions of Society of Actuaries 1959, Vol. 11, No. 31.

Description: In this session, attendees will learn to model historical mortality rates and to forecast their possible future scenarios, using a freely available and well-tested toolkit written in open source R. The core of the toolkit is implemented in the R package StMoMo (https://CRAN.R-project.org/package=StMoMo) and enables a practitioner to derive best estimate and measurements of uncertainty using academically robust demographic and actuarial mortality projection models.

Description: In this session, the presenters will discuss (1) results from a recent study of credibility applications in the pricing of group long term disability business, (2) morbidity experience from individual disability business, and (3) lessons can be learned from each line of business.

Description: The presenters will dig into the little rider that most actuaries don't spend much time thinking about. A regulator, a direct writer and a consultant will discuss their thoughts on this rider and point out areas where actuaries should focus before deeming it insignificant. Topics will include the current study underway to update the industry experience study (most recently done in 1952), underwriting considerations, interactions with other riders, benefit designs, unique issues on UL policies, tax implications and reserving considerations

Description: This presentation is a concurrent session from the 1980 Annual Meeting of the Society of Actuaries, held October 20-22 in Montreal. This session was arranged by the American Statistical Association, ‘ASA,’ and the five panelists are biostatisticians, the moderator being the sole actuary. It is the result of efforts by the ASA and SOA to work together and provide sessions at each other’s meetings. The panelists discuss specialized techniques developed for making greater use of noninsurance studies such as medical follow-ups and clinical trial analyses, which may, because of their nature, involve relatively small groups, and compare them with the more traditional actuarial methodology. Discussion from participants is included. From the Record of Society of Actuaries, Volume 6, No. 4.